DLX105
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for DLX105, covering 2010-09-24 to 2013-01-08. Get the full timeline:
Most recent: Clinical Trial Update: Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris [Phase 1, Phase 2]